Intranasal P Particle Vaccine Provided Partial Cross-Variant Protection against Human GII.4 Norovirus Diarrhea in Gnotobiotic Pigs

Median infectious dose of human norovirus GII.4 in gnotobiotic pigs is decreased by simvastatin treatment and increased by age

(2013) T. Bui et al.   JOURNAL OF GENERAL VIROLOGY

Burden of Norovirus Gastroenteritis in the Ambulatory Setting--United States, 2001-2009

(2013) P. A. Gastanaduy et al.   JOURNAL OF INFECTIOUS DISEASES

Emergence of New Pandemic GII.4 Sydney Norovirus Strain Correlates With Escape From Herd Immunity

(2013) Kari Debbink et al.   JOURNAL OF INFECTIOUS DISEASES

Persistent Enteric Murine Norovirus Infection Is Associated with Functionally Suboptimal Virus-Specific CD8 T Cell Responses

(2013) V. T. Tomov et al.   JOURNAL OF VIROLOGY

Norovirus and Medically Attended Gastroenteritis in U.S. Children

(2013) Daniel C. Payne et al.   NEW ENGLAND JOURNAL OF MEDICINE

Norovirus P Particle Efficiently Elicits Innate, Humoral and Cellular Immunity

(2013) Hao Fang et al.   PLoS One

Identification of Immune and Viral Correlates of Norovirus Protective Immunity through Comparative Study of Intra-Cluster Norovirus Strains

(2013) Shu Zhu et al.   PLoS Pathogens

Intranasal vaccination with an adjuvanted Norwalk virus-like particle vaccine elicits antigen-specific B memory responses in human adult volunteers

(2012) Karina Ramirez et al.   CLINICAL IMMUNOLOGY

The formation of P particle increased immunogenicity of norovirus P protein

(2012) Ming Tan et al.   IMMUNOLOGY

CD4+ CD25− FoxP3+ regulatory cells are the predominant responding regulatory T cells after human rotavirus infection or vaccination in gnotobiotic pigs

(2012) Ke Wen et al.   IMMUNOLOGY

Noroviruses: The Perfect Human Pathogens?

(2012) A. J. Hall   JOURNAL OF INFECTIOUS DISEASES

Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus

(2012) Ming Tan et al.   Nanomedicine

Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 Agonist, Promotes Potent Systemic and Mucosal Responses to Intranasal Immunization with HIVgp140

(2012) Mauricio A. Arias et al.   PLoS One

The potential economic value of a human norovirus vaccine for the United States

(2012) Sarah M. Bartsch et al.   VACCINE

Immunogenicity and specificity of norovirus Consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulations

(2012) Gabriel I. Parra et al.   VACCINE

Norovirus Immunity and the Great Escape

(2012) Kari Debbink et al.   PLoS Pathogens

A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles

(2011) Kirsi Tamminen et al.   IMMUNOLOGY

Genetic Mapping of a Highly Variable Norovirus GII.4 Blockade Epitope: Potential Role in Escape from Human Herd Immunity

(2011) K. Debbink et al.   JOURNAL OF VIROLOGY

Norovirus Vaccine against Experimental Human Norwalk Virus Illness

(2011) Robert L. Atmar et al.   NEW ENGLAND JOURNAL OF MEDICINE

High dose and low dose Lactobacillus acidophilus exerted differential immune modulating effects on T cell immune responses induced by an oral human rotavirus vaccine in gnotobiotic pigs

(2011) Ke Wen et al.   VACCINE

Serological Correlate of Protection against Norovirus‐Induced Gastroenteritis

(2010) Amanda Reeck et al.   JOURNAL OF INFECTIOUS DISEASES

Adjuvanted Intranasal Norwalk Virus‐Like Particle Vaccine Elicits Antibodies and Antibody‐Secreting Cells That Express Homing Receptors for Mucosal and Peripheral Lymphoid Tissues

(2010) Samer S. El‐Kamary et al.   JOURNAL OF INFECTIOUS DISEASES

COMMENTARY: Acceptable Levels of Endotoxin in Vaccine Formulations During Preclinical Research

(2010) Luis A. Brito et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Genetic and Phenotypic Characterization of GII-4 Noroviruses That Circulated during 1987 to 2008

(2010) Y. Yang et al.   JOURNAL OF VIROLOGY

Norovirus P Particle, a Novel Platform for Vaccine Development and Antibody Production

(2010) M. Tan et al.   JOURNAL OF VIROLOGY

Alphavirus-Adjuvanted Norovirus-Like Particle Vaccines: Heterologous, Humoral, and Mucosal Immune Responses Protect against Murine Norovirus Challenge

(2009) A. D. LoBue et al.   JOURNAL OF VIROLOGY

Noroviruses: A comprehensive review

(2008) Manish M. Patel et al.   JOURNAL OF CLINICAL VIROLOGY

Virus-specific intestinal IFN-γ producing T cell responses induced by human rotavirus infection and vaccines are correlated with protection against rotavirus diarrhea in gnotobiotic pigs

(2008) Lijuan Yuan et al.   VACCINE

Noroviral P particle: Structure, function and applications in virus–host interaction

(2008) Ming Tan et al.   VIROLOGY

Mechanisms of GII.4 Norovirus Persistence in Human Populations

(2008) Lisa C Lindesmith et al.   PLOS MEDICINE

Immune Mechanisms Responsible for Vaccination against and Clearance of Mucosal and Lymphatic Norovirus Infection

(2008) Karen A. Chachu et al.   PLoS Pathogens